Alemtuzumab (Campath-1H) and Tacrolimus Monotherapy After Renal Transplantation: Results of a Prospective Randomized Trial
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Transplantation,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2008.02273.x/fullpdf
Reference15 articles.
1. Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation;Srinivas;Am J Transplant,2007
2. Clinical tolerance: The end of the beginning;Monaco;Transplantation,2004
3. Transplant tolerance in non-human primates: Progress, current challenges and unmet needs;Kean;Am J Transplant,2006
4. Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin;Kirk;Transplantation,2005
5. Results from a Human Renal Allograft Tolerance Trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (Campath-1H);Kirk;Transplantation,2003
Cited by 100 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis;Transplantation Reviews;2024-07
2. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08
3. Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials;Annals of Transplantation;2021-12-14
4. Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients;Canadian Journal of Infectious Diseases and Medical Microbiology;2020-10-10
5. Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients;BMC Nephrology;2020-05-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3